Literature DB >> 20039698

Synthesis of tetrahydropyrroloiminoquinone alkaloids based on electrochemically generated hypervalent iodine oxidative cyclization.

Keisuke Inoue1, Yuichi Ishikawa, Shigeru Nishiyama.   

Abstract

An approach to the synthesis of the tetrahydropyrroloiminoquinone alkaloids has been developed and applied to the preparation of N-1-beta-D-ribofuranosyltetrahydropyrroloiminoquinones. The strategy utilizes oxidative cyclization of aryl-methoxyamides by hypervalent iodine to construct the quinoline framework shared by members of this alkaloid family. The hypervalent iodine oxidant is generated in situ by anodic oxidation of iodobenzene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039698     DOI: 10.1021/ol902566p

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance.

Authors:  Ming Yan; Yu Kawamata; Phil S Baran
Journal:  Chem Rev       Date:  2017-10-09       Impact factor: 60.622

2.  A Convenient C-H Functionalization Platform for Pyrroloiminoquinone Alkaloid Synthesis.

Authors:  Myles W Smith; Isaac D Falk; Hideya Ikemoto; Noah Z Burns
Journal:  Tetrahedron       Date:  2019-05-08       Impact factor: 2.457

Review 3.  Recent advances in the electrochemical construction of heterocycles.

Authors:  Robert Francke
Journal:  Beilstein J Org Chem       Date:  2014-12-03       Impact factor: 2.883

4.  C-H Oxygenation Reactions Enabled by Dual Catalysis with Electrogenerated Hypervalent Iodine Species and Ruthenium Complexes.

Authors:  Leonardo Massignan; Xuefeng Tan; Tjark H Meyer; Rositha Kuniyil; Antonis M Messinis; Lutz Ackermann
Journal:  Angew Chem Int Ed Engl       Date:  2020-01-09       Impact factor: 15.336

Review 5.  Organic Electrochemistry: Molecular Syntheses with Potential.

Authors:  Cuiju Zhu; Nate W J Ang; Tjark H Meyer; Youai Qiu; Lutz Ackermann
Journal:  ACS Cent Sci       Date:  2021-03-09       Impact factor: 14.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.